Testing AK139 in healthy volunteers for safety
This early-phase trial tests a new medication called AK139 in healthy volunteers to see if it is safe and how the body handles it. Participation helps researchers understand the drug before it is studied in people with a specific disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a healthy adult between 18 and 55 years old.
- Your weight must be at least 45 kg (for women) or 50 kg (for men), and your body mass index (BMI) must be between 19 and 26.
- You must not have any major medical conditions affecting your heart, brain, lungs, liver, kidneys, or other body systems.
- You must not have participated in another drug study within the last 3 months.
- You must not have a history of drug abuse or have tested positive for drugs at screening.
- If you are a woman who could become pregnant, you must have a negative pregnancy test at screening.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how a new drug (AK104) is processed in the body by comparing it to a known similar drug. It is for healthy men and aims to make sure the new drug behaves the same, which could help in future treatments for conditions like cancer.
This study tests a new medicine, KR23343, in healthy adults to see how the body handles it at different doses. It helps find the right dose and check for any early side effects.
This study is testing a new medication called AKB-9090 for the first time in people. It will help find out how the drug works in the body and how safe it is. The study is looking for healthy volunteers.
This trial tests a new drug called AK0610 in healthy volunteers aged 18 to 50. It helps researchers understand how the drug works in the body and whether it is safe before moving to larger studies.
This study tests a new medicine called AK0406, given as an injection, to see if it is safe and how the body handles it in healthy volunteers. It helps find the right dose for future studies.
This early-stage trial tests a new medicine called AK152 in two groups: healthy volunteers and people with Alzheimer's disease or mild memory problems. For Alzheimer's patients, the study looks at whether the drug safely targets amyloid plaques in the brain.
Hear when a new Healthy Subjects trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.